Literature DB >> 12088439

Spiroidesin, a novel lipopeptide from the cyanobacterium Anabaena spiroides that inhibits cell growth of the cyanobacterium Microcystis aeruginosa.

Kunimitsu Kaya1, Aparat Mahakhant, Ladda Keovara, Tomoharu Sano, Takuya Kubo, Hiroo Takagi.   

Abstract

Spiroidesin (1), a novel D-amino acid-containing linear lipopeptide, was isolated from waterblooms of the cyanobacterium Anabaena spiroides. The structure was identified by 2D NMR and chemical degradation analyses. Spiroidesin inhibited cell growth of the toxic cyanobacterium Microcystis aeruginosa (IC(50), 1.6 x 10(-6) M).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088439     DOI: 10.1021/np010660x

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  5 in total

1.  Microcystins and cyanophyte extracts inhibit or promote the photosynthesis of fluvial algae. Ecological and management implications.

Authors:  Laura García-Espín; Enrique A Cantoral; Antonia D Asencio; Marina Aboal
Journal:  Ecotoxicology       Date:  2017-04-05       Impact factor: 2.823

Review 2.  Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery.

Authors:  George E Chlipala; Shunyan Mo; Jimmy Orjala
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

3.  Investigation of antimicrobial and protease-inhibitory activity from cultured cyanobacteria.

Authors:  George Chlipala; Shunyan Mo; Esperanza J Carcache de Blanco; Aiko Ito; Stanley Bazarek; Jimmy Orjala
Journal:  Pharm Biol       Date:  2009-01       Impact factor: 3.503

4.  A novel biosurfactant, 2-acyloxyethylphosphonate, isolated from waterblooms of Aphanizomenon flos-aquae.

Authors:  Kunimitsu Kaya; Louise F Morrison; Geoffrey A Codd; James S Metcalf; Tomoharu Sano; Hiroo Takagi; Takuya Kubo
Journal:  Molecules       Date:  2006-07-22       Impact factor: 4.411

5.  Anabaenolysins, novel cytolytic lipopeptides from benthic Anabaena cyanobacteria.

Authors:  Jouni Jokela; Linn Oftedal; Lars Herfindal; Perttu Permi; Matti Wahlsten; Stein Ove Døskeland; Kaarina Sivonen
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.